Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome

• Xiaoman Du, MD,
• Yudi Chen, MD,
• Jianmin Chang, MD,
• Xuelin Sun, MD, PhD,
• Yue Zhang, MS,
• Meng Zhang, BM,
• Marcus Maurer, MD, PhD,
• Yanming Li, MD,
• Zuotao Zhao, MD, PhD,
• Xunliang Tong, MD, PhD

Affiliations

Xiaoman Du, MD

Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Yudi Chen, MD

Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Jianmin Chang, MD

Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Xuelin Sun, MD, PhD

Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Yue Zhang, MS

Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Meng Zhang, BM

Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Marcus Maurer, MD, PhD

Institute of Allergology, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany

Yanming Li, MD

Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Zuotao Zhao, MD, PhD

Department of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Beijing, People’s Republic of China; Zuotao Zhao, MD, PhD, Department of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Xishiku Avenue No. 8, Xi Cheng District, Beijing, People’s Republic of China.

Xunliang Tong, MD, PhD

Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; Correspondence to: Xunliang Tong, MD, PhD, Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Da Hua Avenue No.1, Dong Cheng District, Beijing, People’s Republic of China.